Table 2 Significant differentially expressed non-annotated genes in skeletal muscle after acute systemic administration of β₂-AR agonist

RIKEN cDNA 3300001A09

XM_134869.3

+ 4.68

NS

+ 5.32

0.042

RIKEN cDNA 1200016E24

XM_489305

+ 4.90

0.016

+ 2.32

NS

cDNA sequence BC036718

NM_153136.1

+ 1.81

NS

+ 3.96

0.004

RIKEN cDNA C330006P03

N/A

+ 1.11

NS

+ 3.78

0.006

RIKEN cDNA B430214A04

NM_146018.1

+ 1.42

NS

+ 3.05

0.004

RIKEN cDNA 6430548M08

NM_172286

+ 1.15

NS

+ 2.94

0.025

RIKEN cDNA A830030H10

AK080627

+ 1.96

NS

+ 2.69

0.025

RIKEN cDNA 4833406M21

N/A

+ 1.38

NS

+ 2.66

0.004

RIKEN cDNA 1300002F13

NM_133753.1

+ 2.54

0.013

+ 1.11

NS

RIKEN cDNA 9530083O12

N/A

+ 2.53

0.013

+ 1.69

NS

RIKEN cDNA 1200015N20

NM_024244.3

- 1.06

NS

+ 2.52

0.010

Hypothetical protein 4933408F15

NM_172715.1

+ 1.24

NS

+ 2.52

0.010

RIKEN cDNA A730009E18

N/A

+ 1.34

NS

+ 2.42

0.005

RIKEN cDNA A430107N12

N/A

+ 1.04

NS

+ 2.21

0.036

RIKEN cDNA 5830446M03

NM_133934.2

+ 1.32

NS

+ 2.14

0.016

Similar to heart alpha-kinase (LOC381181)

XM_355107.1

+ 1.08

NS

+ 2.11

0.009

RIKEN cDNA 2810426P10

XM_148728.1

+ 1.03

NS

+ 2.08

0.008

Weakly similar to protein transport protein SEC24A (SEC24-RELATED PROTEIN A)

AK038836

+ 2.07

0.041

+ 1.29

NS

RIKEN cDNA 2310040A07

N/A

+ 1.06

NS

+ 2.07

0.047

RIKEN cDNA 8030450I18

N/A

+ 1.33

NS

+ 2.05

0.043

RIKEN cDNA 3021401C12

N/A

+ 1.17

NS

+ 1.98

0.015

RIKEN cDNA 2900078C09

N/A

+ 1.46

NS

+ 1.95

0.039

RIKEN cDNA 1110033I14

XM_126635.1

+ 1.72

NS

+ 1.95

0.044

cDNA sequence BC023105

NM_145357

- 1.07

NS

- 1.92

0.039